Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC   US4525361055

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
06/26/2015 06/29/2015 06/30/2015 07/01/2015 07/02/2015 Date
0.48(c) 0.4699(c) 0.472(c) 0.47(c) 0.49(c) Last
669 379 716 516 170 055 190 779 145 255 Volume
-3.61% -2.10% +0.45% -0.42% +4.26% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -15,7 M
Net income 2015 -14,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 -
EBIT 2016 -21,5 M
Net income 2016 -21,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 0
Capitalization 44,2 M
More Financials
Company
ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of cancers.Immunotherapy is an emerging approach to treating cancer in which a patients own immune system is stimulated to target tumor antigens, which are... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
07/02 IMMUNOCELLULAR THERAPEUTICS : Submission of Matters to a Vote of Security Holder..
07/01 IMMUNOCELLULAR THERAPEUTICS : Establishes Agreement with Pure MHC for Novel Qual..
06/29 IMMUNOCELLULAR THERAPEUTICS : to Present at Cantor Fitsgerald Inaugural Healthca..
06/24 IMMUNOCELLULAR THERAPEUTICS : Enters into Manufacturing Agreement with PCT LLC, ..
06/23 IMMUNOCELLULAR THERAPEUTICS : Enters into Agreement with Pure MHC
06/22 IMMUNOCELLULAR THERAPEUTICS : Establishes Agreement with Pure MHC for Novel Qual..
06/18 IMMUNOCELLULAR THERAPEUTICS : Entry into a Material Definitive Agreement, Other ..
06/16 IMMUNOCELLULAR THERAPEUTICS : enters into manufacturing agreement with PCT for U..
More news
Sector news : Biotechnology & Medical Research - NEC
07/02 QUINTILES TRANSNATIONAL : and Quest Diagnostics Launch Q2 Solutions
07/01 QUINTILES TRANSNATIONAL : ’ Second Quarter 2015 Earnings Call Scheduled fo..
06/30 ISIS PHARMACEUTICALS : Webcast Alert: Corporate Presentation at the 2015 Isis Ph..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/22 NEXT WEEK IN BIOTECH : Salix/Valeant PDUFA, ASCO, Brain Tumor Summit
05/19 Immunocellular Therapeutics amends license agreement with Cedars-Sinai
05/12 ImmunoCellular's (IMUC) CEO Andrew Gengos on Q1 2015 Results - Earnings Call ..
05/12 ImmunoCellular Therapeutics net loss improves in Q1
05/11 ImmunoCellular Therapeutics beats by $0.01


Comments 
Advertisement
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions